BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat ketamine models resembling negative-like symptoms of schizophrenia
Whrend einzelne Wachstumsfaktoren typischerweise spezifische Bedingungen oder Gewebe erfordern, war BPC-157 allein konsistent wirksam in allen Modellen akuter und chronischer Schdigung des gesamten GI-Trakts (Seiwerth et al., 2018)
The peptides seemed to shift the tissue environment away from neurotoxicity toward repair and calm
You might also feel numbness or tingling in the hands and feet , have trouble walking, or notice changes in thinking
12 pounds per week (68 pounds per month) , though results depend on factors like adherence, activity level, and metabolism
PMID 27468410